VivoSim Labs
VIVS
119 hedge funds and large institutions have $61.4M invested in VivoSim Labs in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 9 closing their positions.
68% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 22
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
2% more funds holding
Funds holding: 117 → 119 (+2)
0.01% more ownership
Funds ownership: 0.1% → 0.11% (+0.01%)
8% less capital invested
Capital invested by funds: $67M → $61.4M (-$5.63M)
91% less call options, than puts
Call options by funds: $48K | Put options by funds: $527K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$2.62M |
| 2 |
Renaissance Technologies
New York
|
+$776K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$710K |
| 4 |
BlackRock
New York
|
+$466K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$361K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.44M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
-$982K |
| 3 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$167K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$99K |
| 5 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
-$73K |
VIVS Hedge Fund Activity: Q3 2017 in Review
119 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q3 2017, worth a combined $61.4M — down 8.4% from $67M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new VIVS positions and 9 closed out — a net gain of 5 holders — while 37 added to existing stakes and 22 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $2.62M. The largest seller was UBS Group, cutting an estimated $1.44M.
- 119 institutional investors held VivoSim Labs (VIVS) as of Q3 2017, up from 117 in Q2 2017.
- Funds reported $61.4M of VivoSim Labs stock for Q3 2017, down 8.4% quarter-over-quarter.
- 14 funds opened new VivoSim Labs positions in Q3 2017 and 9 closed out, a net change of +5 holders.
- The largest VivoSim Labs buyer in Q3 2017 was ARK Investment Management, an estimated $2.62M added.
- The largest VivoSim Labs seller in Q3 2017 was UBS Group, an estimated $1.44M sold.
Based on aggregated 13F filings for Q3 2017.